0000950170-23-034156.txt : 20230724 0000950170-23-034156.hdr.sgml : 20230724 20230724193909 ACCESSION NUMBER: 0000950170-23-034156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230721 FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dworak Leiden CENTRAL INDEX KEY: 0001986012 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 231106151 MAIL ADDRESS: STREET 1: C/O TSCAN THERAPEUTICS, INC. STREET 2: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml 4 X0508 4 2023-07-21 0001783328 TScan Therapeutics, Inc. TCRX 0001986012 Dworak Leiden C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 false true false false Chief Accounting Officer false Stock Option (Right to Buy) 2.23 2023-07-21 4 A false 25000 0 A 2033-07-20 Voting Common Stock 25000 25000 D The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of July 21, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer. /s/ Leiden Dworak 2023-07-24